Skip to content

Effects of weight loss on adipose tissue β2-adrenoceptor-stimulated lipolysis: role of adipose tissue oxidative stress and hypoxia

Effects of weight loss on adipose tissue β2-adrenoceptor-stimulated lipolysis: role of adipose tissue oxidative stress and hypoxia - Weight loss and β2-adrenoceptor-stimulated lipolysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36127
Enrollment
37
Registered
2011-06-30
Start date
2011-10-28
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vetweefseldisfunctie bij obesitas obesity

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - All subjects entering the CO-Eur programme (life style intervention at the obesity treatment centre CO-Eur in Heerlen). Co-Eur only includes subjects with age>18 years and BMI>30kg/m2 - No more than 3 kg weight change in the past 3 months - age>18 years

Exclusion criteria

Exclusion criteria: - Smoking * Diabetes * (Medicinal) use of β-blockers or β-agonists * Pregnant women - (medicinal) use of anticoagulantia or blood clotting problems

Design outcomes

Primary

MeasureTime frame
For the pre- and post-measurement a subcutaneous adipose tissue biopsy of about 1 gram will be taken. one part will be used to measure sensitivity to β2-AR stimulation of lipolysis with salbutamol in adipocytes isolated from the biopsy.

Secondary

MeasureTime frame
Another part of the adipose tissue biopsy will be used to measure markers of local adipose tissue hypoxia and oxidative stress with western blot and PCR techniques. In addition a 5 ml venous blood sample and a small urine sample will be collected at both occasions. Markers of systemic oxidative stress will be measured in plasma and urine samples.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)